Atherosclerosis Drugs Market Size, Share & Forecast Report, 2026–2035
Atherosclerosis Drugs Market was valued at USD 34.6 billion in 2025 and is projected to cross USD 47.8 billion by the end of 2035, expanding at more than 3.3% CAGR during the forecast period. The market is supported by the persistent global burden of cardiovascular disease, increasing awareness of cholesterol management, improvements in lipid-lowering therapies, and the introduction of innovative treatments for patients who do not respond adequately to conventional medicines.
